Pharmacokinetic and Pharmacodynamic Assessment of Oral Valganciclovir in the Treatment of Symptomatic Congenital Cytomegalovirus Disease
Year: 2008
Type: article
Study design: Clinical Trial
DOI: 10.1086/528376
Authors: David W. Kimberlin, Edward P. Acosta, Pablo J. Sánchez, Sunil Sood, Vish Agrawal, James Homans, Richard F. Jacobs, David Lang, Jose R. Romero, Jill Griffin, Gretchen A. Cloud, Fred D. Lakeman, Richard J. Whitley
Institutions: University of Alabama at Birmingham, The University of Texas Southwestern Medical Center, Albert Einstein College of Medicine, Schneider Children's Hospital, John H. Stroger, Jr. Hospital of Cook County, University of Southern California, University of Arkansas for Medical Sciences, Children's Hospital of Orange County, Creighton University, University of Nebraska Medical Center
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Awards: G129627632, Clinical Trials for Antiviral Therapies, G2023386004, G26948563, CLINICAL STUDIES OF THERAPIES FOR VIRUS INFECTIONS, G4162165377, G446718224, G4788654412, General Clinical Research Center, TRIAL ON ANTIVIRALS FOR SEVERE HERPES VIRUS INFECTIONS, G763831136, G8254531296, THERAPIES FOR SEVERE HERPES VIRUS INFECTION
OpenAlex ID: W2132533458
